Reason for request

Inclusion on list: First listing

Summary of opinion

Favourable opinion for reimbursement for:

  • Correction of hypoxia of various aetiologies requiring normobaric or hyperbaric oxygen therapy, 
  • Supply of ventilators in anaesthesia or intensive care, 
  • Use as a carrier for inhaled medicinal products in nebuliser therapy, 
  • Treatment of acute attacks of cluster headache.

No clinical added value of the new forms compared to the forms already available.


Clinical Benefit

Substantial

The Committee deems that clinical benefit of these new forms of the medicinal product MEDICINAL OXYGEN AIR LIQUIDE SANTE FRANCE 200 bar inhalation gas, is high in the MA indications.


Clinical Added Value

no clinical added value

This medicinal product is a range supplement that does not provide any clinical added value (CAV V) compared to the forms already listed.


Contact Us

Évaluation des médicaments